Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis

Heart Lung and Circulation

Volumn 26, Issue 9, 2017, Pages 887-893

  Lau, Dennis H ^a   Linz, Dominik ^a,b   Schotten, Ulrich ^c   Mahajan, Rajiv ^a   Sanders, Prashanthan ^a   Kalman, Jonathan M ^d  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b SAARLAND UNIVERSITY   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Atrial fibrillation; Atrial fibrosis; Ectopic foci; Mapping; Remodelling; Rotors

Indexed keywords

GADOLINIUM;

ATRIAL FIBROSIS; CONTRAST ENHANCEMENT; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ELECTRODE; HEART ATRIUM REMODELING; HEART MUSCLE FIBROSIS; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PAROXYSMAL ATRIAL FIBRILLATION; PERSISTENT ATRIAL FIBRILLATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FIBROSIS; HEART ATRIUM; HEART MUSCLE CONDUCTION SYSTEM; PAROXYSMAL TACHYCARDIA; PATHOLOGY; PATHOPHYSIOLOGY;

ATRIAL FIBRILLATION; ATRIAL REMODELING; ELECTROCARDIOGRAPHY; FIBROSIS; HEART ATRIA; HEART CONDUCTION SYSTEM; HUMANS; TACHYCARDIA, PAROXYSMAL;

EID: 85020463831     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2017.05.119     Document Type: Review

References (62)

1. Schotten, U., Verheule, S., Kirchhof, P., Goette, A., Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 91 (2011), 265–325.
2. Lau, D.H., Schotten, U., Mahajan, R., Antic, N.A., Hatem, S.N., Pathak, R.K., et al. Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications. Eur Heart J 37 (2016), 1573–1581.
3. Andrade, J., Khairy, P., Dobrev, D., Nattel, S., The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res 114 (2014), 1453–1468.
4. Jahangir, A., Lee, V., Friedman, P.A., Trusty, J.M., Hodge, D.O., Kopecky, S.L., et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 115 (2007), 3050–3056.
5. Gillis, A.M., Rose, M.S., Temporal patterns of paroxysmal atrial fibrillation following DDDR pacemaker implantation. Am J Cardiol 85 (2000), 1445–1450.
6. Charitos, E.I., Purerfellner, H., Glotzer, T.V., Ziegler, P.D., Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices. J Am Coll Cardiol 63 (2014), 2840–2848.
7. Nabauer, M., Gerth, A., Limbourg, T., Schneider, S., Oeff, M., Kirchhof, P., et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace 11 (2009), 423–434.
8. Teh, A.W., Kistler, P.M., Lee, G., Medi, C., Heck, P.M., Spence, S.J., et al. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease. J Cardiovasc Electrophysiol 23 (2012), 232–238.
9. Teh, A.W., Kalman, J.M., Kistler, P.M., Lee, G., Sutherland, F., Morton, J.B., et al. Prevalence of fractionated electrograms in the coronary sinus: comparison between patients with persistent or paroxysmal atrial fibrillation and a control population. Heart Rhythm 7 (2010), 1200–1204.
10. Sanders, P., Berenfeld, O., Hocini, M., Jais, P., Vaidyanathan, R., Hsu, L.F., et al. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation 112 (2005), 789–797.
11. Stiles, M.K., Brooks, A.G., Kuklik, P., John, B., Dimitri, H., Lau, D.H., et al. High-density mapping of atrial fibrillation in humans: relationship between high-frequency activation and electrogram fractionation. J Cardiovasc Electrophysiol 19 (2008), 1245–1253.
12. Allessie, M.A., de Groot, N.M., Houben, R.P., Schotten, U., Boersma, E., Smeets, J.L., et al. Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation. Circ Arrhythm Electrophysiol 3 (2010), 606–615.
13. de Groot, N.M., Houben, R.P., Smeets, J.L., Boersma, E., Schotten, U., Schalij, M.J., et al. Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: epicardial breakthrough. Circulation 122 (2010), 1674–1682.
14. Lau, D.H., Mackenzie, L., Kelly, D.J., Psaltis, P.J., Brooks, A.G., Worthington, M., et al. Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model. Heart Rhythm 7 (2010), 1282–1290.
15. Lau, D.H., Mackenzie, L., Kelly, D.J., Psaltis, P.J., Worthington, M., Rajendram, A., et al. Short-term hypertension is associated with the development of atrial fibrillation substrate: a study in an ovine hypertensive model. Heart Rhythm 7 (2010), 396–404.
16. Kistler, P.M., Sanders, P., Dodic, M., Spence, S.J., Samuel, C.S., Zhao, C., et al. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J 27 (2006), 3045–3056.
17. Lau, D.H., Shipp, N.J., Kelly, D.J., Thanigaimani, S., Neo, M., Kuklik, P., et al. Atrial arrhythmia in ageing spontaneously hypertensive rats: unraveling the substrate in hypertension and ageing. PLoS One, 8, 2013, e72416.
18. Li, D., Fareh, S., Leung, T.K., Nattel, S., Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100 (1999), 87–95.
19. Lau, D.H., Psaltis, P.J., Mackenzie, L., Kelly, D.J., Carbone, A., Worthington, M., et al. Atrial remodeling in an ovine model of anthracycline-induced nonischemic cardiomyopathy: remodeling of the same sort. J Cardiovasc Electrophysiol 22 (2011), 175–182.
20. Linz, D., Hohl, M., Dhein, S., Ruf, S., Reil, J.C., Kabiri, M., et al. Cathepsin A mediates susceptibility to atrial tachyarrhythmia and impairment of atrial emptying function in Zucker diabetic fatty rats. Cardiovasc Res 110 (2016), 371–380.
21. Abed, H.S., Samuel, C.S., Lau, D.H., Kelly, D.J., Royce, S.G., Alasady, M., et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm 10 (2013), 90–100.
22. Mahajan, R., Lau, D.H., Brooks, A.G., Shipp, N.J., Manavis, J., Wood, J.P., et al. Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity. J Am Coll Cardiol 66 (2015), 1–11.
23. Iwasaki, Y.K., Kato, T., Xiong, F., Shi, Y.F., Naud, P., Maguy, A., et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol 64 (2014), 2013–2023.
24. Verheule, S., Tuyls, E., Gharaviri, A., Hulsmans, S., van Hunnik, A., Kuiper, M., et al. Loss of continuity in the thin epicardial layer because of endomysial fibrosis increases the complexity of atrial fibrillatory conduction. Circ Arrhythm Electrophysiol 6 (2013), 202–211.
25. Eckstein, J., Zeemering, S., Linz, D., Maesen, B., Verheule, S., van Hunnik, A., et al. Transmural conduction is the predominant mechanism of breakthrough during atrial fibrillation: evidence from simultaneous endo-epicardial high-density activation mapping. Circ Arrhythm Electrophysiol 6 (2013), 334–341.
26. Hatem, S.N., Sanders, P., Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res 102 (2014), 205–213.
27. Polontchouk, L., Haefliger, J.A., Ebelt, B., Schaefer, T., Stuhlmann, D., Mehlhorn, U., et al. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 38 (2001), 883–891.
28. Rucker-Martin, C., Milliez, P., Tan, S., Decrouy, X., Recouvreur, M., Vranckx, R., et al. Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res 72 (2006), 69–79.
29. Verheule, S., Eckstein, J., Linz, D., Maesen, B., Bidar, E., Gharaviri, A., et al. Role of endo-epicardial dissociation of electrical activity and transmural conduction in the development of persistent atrial fibrillation. Prog Biophys Mol Biol 115 (2014), 173–185.
30. Maesen, B., Zeemering, S., Afonso, C., Eckstein, J., Burton, R.A., van Hunnik, A., et al. Rearrangement of atrial bundle architecture and consequent changes in anisotropy of conduction constitute the 3-dimensional substrate for atrial fibrillation. Circ Arrhythm Electrophysiol 6 (2013), 967–975.
31. Medi, C., Kalman, J.M., Spence, S.J., Teh, A.W., Lee, G., Bader, I., et al. Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation. J Cardiovasc Electrophysiol 22 (2011), 1317–1324.
32. Dimitri, H., Ng, M., Brooks, A.G., Kuklik, P., Stiles, M.K., Lau, D.H., et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm 9 (2012), 321–327.
33. Sanders, P., Morton, J.B., Davidson, N.C., Spence, S.J., Vohra, J.K., Sparks, P.B., et al. Electrical Remodeling of the Atria in Congestive Heart Failure. Electrophysiological and Electroanatomic Mapping in Humans 108 (2003), 1461–1468.
34. Malcolme-Lawes, L.C., Juli, C., Karim, R., Bai, W., Quest, R., Lim, P.B., et al. Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: a 2-center study. Heart Rhythm 10 (2013), 1184–1191.
35. Harrison, J.L., Jensen, H.K., Peel, S.A., Chiribiri, A., Grondal, A.K., Bloch, L.O., et al. Cardiac magnetic resonance and electroanatomical mapping of acute and chronic atrial ablation injury: a histological validation study. Eur Heart J 35 (2014), 1486–1495.
36. Konings, K.T., Kirchhof, C.J., Smeets, J.R., Wellens, H.J., Penn, O.C., Allessie, M.A., High-density mapping of electrically induced atrial fibrillation in humans. Circulation 89 (1994), 1665–1680.
37. Fiala, M., Wichterle, D., Chovancik, J., Bulkova, V., Wojnarova, D., Nevralova, R., et al. Left atrial voltage during atrial fibrillation in paroxysmal and persistent atrial fibrillation patients. Pacing Clin Electrophysiol 33 (2010), 541–548.
38. Daccarett, M., Badger, T.J., Akoum, N., Burgon, N.S., Mahnkopf, C., Vergara, G., et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol 57 (2011), 831–838.
39. Haissaguerre, M., Shah, A.J., Cochet, H., Hocini, M., Dubois, R., Efimov, I., et al. Intermittent drivers anchoring to structural heterogeneities as a major pathophysiological mechanism of human persistent atrial fibrillation. J Physiol 594 (2016), 2387–2398.
40. Marrouche, N.F., Wilber, D., Hindricks, G., Jais, P., Akoum, N., Marchlinski, F., et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA 311 (2014), 498–506.
41. Rolf, S., Kircher, S., Arya, A., Eitel, C., Sommer, P., Richter, S., et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 7 (2014), 825–833.
42. Wu, S.H., Jiang, W.F., Gu, J., Zhao, L., Wang, Y.L., Liu, Y.G., et al. Benefits and risks of additional ablation of complex fractionated atrial electrograms for patients with atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol 169 (2013), 35–43.
43. Narayan, S.M., Krummen, D.E., Shivkumar, K., Clopton, P., Rappel, W.J., Miller, J.M., Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol 60 (2012), 628–636.
44. Haissaguerre, M., Hocini, M., Denis, A., Shah, A.J., Komatsu, Y., Yamashita, S., et al. Driver domains in persistent atrial fibrillation. Circulation 130 (2014), 530–538.
45. Swarup, V., Baykaner, T., Rostamian, A., Daubert, J.P., Hummel, J., Krummen, D.E., et al. Stability of rotors and focal sources for human atrial fibrillation: focal impulse and rotor mapping (FIRM) of AF sources and fibrillatory conduction. J Cardiovasc Electrophysiol 25 (2014), 1284–1292.
46. Kuklik, P., Zeemering, S., van Hunnik, A., Maesen, B., Pison, L., Lau, D.H., et al. Identification of Rotors during Human Atrial Fibrillation Using Contact Mapping and Phase Singularity Detection: Technical Considerations. IEEE Trans Biomed Eng 64 (2017), 310–318.
47. Vijayakumar, R., Vasireddi, S.K., Cuculich, P.S., Faddis, M.N., Rudy, Y., Methodology Considerations in Phase Mapping of Human Cardiac Arrhythmias. Circ Arrhythm Electrophysiol, 9, 2016.
48. Lee, G., Kumar, S., Teh, A., Madry, A., Spence, S., Larobina, M., et al. Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activity. Eur Heart J 35 (2014), 86–97.
49. Walters, T.E., Lee, G., Morris, G., Spence, S., Larobina, M., Atkinson, V., et al. Temporal Stability of Rotors and Atrial Activation Patterns in Persistent Human Atrial Fibrillation. JACC: Clinical Electrophysiology 1 (2015), 14–24.
50. Lim, H.S., Hocini, M., Dubois, R., Denis, A., Derval, N., Zellerhoff, S., et al. Complexity and Distribution of Drivers in Relation to Duration of Persistent Atrial Fibrillation. J Am Coll Cardiol 69 (2017), 1257–1269.
51. Narayan, S.M., Baykaner, T., Clopton, P., Schricker, A., Lalani, G.G., Krummen, D.E., et al. Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation). J Am Coll Cardiol 63 (2014), 1761–1768.
52. Miller, J.M., Kalra, V., Das, M.K., Jain, R., Garlie, J.B., Brewster, J.A., et al. Clinical Benefit of Ablating Localized Sources for Human Atrial Fibrillation: The Indiana University FIRM Registry. J Am Coll Cardiol 69 (2017), 1247–1256.
53. Steinberg, J.S., Shah, Y., Bhatt, A., Sichrovsky, T., Arshad, A., Hansinger, E., et al. Focal impulse and rotor modulation: Acute procedural observations and extended clinical follow-up. Heart Rhythm 14 (2017), 192–197.
54. Buch, E., Share, M., Tung, R., Benharash, P., Sharma, P., Koneru, J., et al. Long-term clinical outcomes of focal impulse and rotor modulation for treatment of atrial fibrillation: A multicenter experience. Heart Rhythm 13 (2016), 636–641.
55. Lau, D.H., Middeldorp, M.E., Brooks, A.G., Ganesan, A.N., Roberts-Thomson, K.C., Stiles, M.K., et al. Aortic stiffness in lone atrial fibrillation: a novel risk factor for arrhythmia recurrence. PLoS One, 8, 2013, e76776.
56. McLellan, A.J., Schlaich, M.P., Taylor, A.J., Prabhu, S., Hering, D., Hammond, L., et al. Reverse cardiac remodeling after renal denervation: Atrial electrophysiologic and structural changes associated with blood pressure lowering. Heart Rhythm 12 (2015), 982–990.
57. Linz, D., van Hunnik, A., Ukena, C., Ewen, S., Mahfoud, F., Schirmer, S.H., et al. Renal denervation: effects on atrial electrophysiology and arrhythmias. Clin Res Cardiol 103 (2014), 765–774.
58. Pathak, R.K., Middeldorp, M.E., Meredith, M., Mehta, A.B., Mahajan, R., Wong, C.X., et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol 65 (2015), 2159–2169.
59. Abed, H.S., Wittert, G.A., Leong, D.P., Shirazi, M.G., Bahrami, B., Middeldorp, M.E., et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA 310 (2013), 2050–2060.
60. Pathak, R.K., Middeldorp, M.E., Lau, D.H., Mehta, A.B., Mahajan, R., Twomey, D., et al. Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation: the ARREST-AF Cohort Study. J Am Coll Cardiol 64 (2014), 2222–2231.
61. Pathak, R.K., Elliott, A., Middeldorp, M.E., Meredith, M., Mehta, A.B., Mahajan, R., et al. Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study. J Am Coll Cardiol 66 (2015), 985–996.
62. Malmo, V., Nes, B.M., Amundsen, B.H., Tjonna, A.E., Stoylen, A., Rossvoll, O., et al. Aerobic Interval Training Reduces the Burden of Atrial Fibrillation in the Short Term: A Randomized Trial. Circulation 133 (2016), 466–473.